Key result
High residual lipid burden after PCI linked to ~4-fold greater risk of non-culprit MACE.
Why the study?
Coronary artery lipid accumulation indicates atherosclerosis, but the clinical significance and prognostic value of residual lipid burden after PCI in AMI patients needed evaluation.
Does high residual lipid burden on OCT predict 5-year non-culprit lesion-related MACE in patients with AMI after successful PCI?
Does high residual lipid burden on OCT predict 5-year non-culprit lesion-related MACE in patients with AMI after successful PCI?
High residual lipid burden assessed by three-vessel OCT after successful PCI in AMI patients is a strong, independent predictor of 5-year non-culprit lesion-related MACE.
High residual lipid burden on post-PCI OCT was associated with higher non-culprit MACE in AMI; hypothesis-generating for targeted lipid strategies pending randomized validation.
Background Coronary artery lipid accumulation is indicative of atherosclerosis. Purpose This study aimed to examine the clinical significance and prognostic value of residual lipid burden (RLB) after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Methods Between January 2017 and December 2021, 1312 patients with AMI who underwent three-vessel optical coherence tomography (OCT) imaging after successful PCI were divided into low RLB group (n=656) and high RLB group (n=656) based on the median value of OCT-derived RLB (total lipid index of all non-culprit lesions). Patients were followed for up to 5 years. Major adverse cardiovascular events (MACE) were recorded. Results The average age was 57.0 years, and 74.9% were male. The high RLB group had more frequent multi-vessel disease (54.6% vs. 24.5%, P<0.001), non-culprit plaque rupture (28.4% vs. 6.1%, P<0.001), thin-cap fibroatheroma (TCFA: 53.8% vs. 11.0%, P<0.001), and other vulnerable plaque features (all P<0.001) compared to the low RLB group. After adjusting for clinical risk factors, a high RLB independently predicted non-culprit plaque rupture, TCFA, and vulnerable plaque features. Patients with a high RLB had a significantly greater incidence of 5-year non-culprit lesion-related MACE (8.4% vs. 2.6%, adjusted hazard ratio [HR]: 3.84, 95% confidence interval [CI]: 1.98-7.45, P<0.001) than patients with a low RLB; and most events were ischemia-driven revascularization (6.5% vs. 1.9%, P<0.001). Moreover, the predictive value of a high RLB was independent of non-culprit TCFA. Conclusions OCT-derived RLB was strongly associated with pancoronary plaque characteristics in AMI patients. A high RLB was predictive of 5-year adverse events independent of TCFA.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2025) studied this question. High residual lipid burden after PCI in AMI patients predicts a 3.84-fold higher 5-year risk of non-culprit lesion-related MACE (8.4% vs 2.6%, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: